General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Sardocor Corp.(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Amgen Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Medtronic, Inc.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Edgewise Therapeutics, Inc.(MODEST), Lexicon Pharmaceuticals, Inc.(MODEST), Space Exploration Technologies Corp.; aka, SpaceX(MODEST)

View Full Disclosure